can women take retatrutide is a triple hormone agonist used for significant weight reduction in individuals with overweight, obesity, and/or type 2 diabetes. It works by activating the GIP, GLP-1, and glucagon receptors, leading to Retatrutide: Is It The Next

Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the direct target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the baseline metabolic terrain any compound acts on

GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials

The JIFSAN-CFS Food Safety Laboratory investigates the ecology, adaptation, and transmission of foodborne pathogens across interconnected food and environmental systems

Many studies have demonstrated that GLP-1 suppresses feeding behaviors and modulates the spontaneous firing activities and/or glutamatergic or GABAergic neurotransmission in multiple brain regions